ImmunoGen, Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ImmunoGen, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q3 2023.
  • ImmunoGen, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 266M shares, a 20.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 266M +45.2M +20.5% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 249M +28.1M +12.7% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 226M +5.53M +2.51% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 226M +5.69M +2.58% Dec 31, 2022 10-Q 2023-11-02
Q3 2022 221M +18.2M +8.99% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 221M +20.4M +10.2% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 221M +20.6M +10.3% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 220M +25.4M +13% Dec 31, 2021 10-K 2023-03-01
Q3 2021 202M +27.9M +16% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 200M +25.7M +14.7% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 200M +25.7M +14.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 195M +44.9M +29.9% Dec 31, 2020 10-K 2022-02-28
Q3 2020 175M +24.9M +16.6% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 175M +24.7M +16.4% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 174M +24.8M +16.6% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 150M +736K +0.49% Dec 31, 2019 10-K 2021-03-01
Q3 2019 150M +150M +100329% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 150M +150M +100480% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 149M +16.4M +12.3% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 149M +16.9M +12.7% Dec 31, 2018 10-K 2020-03-11
Q3 2018 149K* -115M -99.9% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 149K* -89.4M -99.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 133M +43.7M +48.9% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 133M +45.2M +51.8% Dec 31, 2017 10-K 2019-03-01
Q3 2017 116M +28.2M +32.4% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 89.6M +2.39M +2.74% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 89.3M +2.27M +2.61% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 87.3M +261K +0.3% Dec 31, 2016 10-K 2018-03-07
Q3 2016 87.3M +333K +0.38% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 87.2M +630K +0.73% Jun 30, 2016 10-KT 2017-03-03
Q1 2016 87.1M +943K +1.1% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 87M +959K +1.11% Dec 31, 2015 10-Q 2016-02-04
Q3 2015 87M +1.05M +1.23% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 86.6M +676K +0.79% Jun 30, 2015 10-KT 2017-03-03
Q1 2015 86.1M +327K +0.38% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 86.1M +452K +0.53% Dec 31, 2014 10-Q 2015-02-05
Q3 2014 85.9M +658K +0.77% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 85.9M +1.18M +1.39% Jun 30, 2014 10-K 2015-08-27
Q1 2014 85.8M +1.37M +1.62% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 85.6M +1.44M +1.71% Dec 31, 2013 10-Q 2014-02-05
Q3 2013 85.3M +1.15M +1.37% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 84.7M +6.97M +8.96% Jun 30, 2013 10-K 2014-08-28
Q1 2013 84.4M +7.25M +9.39% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 84.2M +7.91M +10.4% Dec 31, 2012 10-Q 2013-01-30
Q3 2012 84.1M +7.7M +10.1% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 77.8M +1.48M +1.94% Jun 30, 2012 10-K 2013-08-29
Q1 2012 77.2M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 76.3M Dec 31, 2011 10-Q 2012-01-31
Q3 2011 76.4M Sep 30, 2011 10-Q 2011-10-31
Q2 2011 76.3M Jun 30, 2011 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.